View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
October 7, 2013

Binder Biomedical gets FDA approval for anterior lumbar fixation system

Binder Biomedical has received US Food and Drug Administration (FDA) approval for its Logic, an anterior lumbar fixation system with a simple, one-step locking mechanism.

By admin-demo

Binder Biomedical has received US Food and Drug Administration (FDA) approval for its Logic, an anterior lumbar fixation system with a simple, one-step locking mechanism.

The new stand-alone intervertebral body fusion device is designed for use in a direct anterior surgical approach for accessing the intervertebral disc space of the patient’s lumbar spine.

The limited release is planned for the first quarter of 2014, with the nationwide launch expected by the fourth quarter of 2014.

Binder Biomedical president Lawrence Binder said: "Our design team has done a great job putting together such a comprehensive system, ensuring that it can be tailored to any surgeon’s preferred surgical technique."

"Our design team has done a great job putting together such a comprehensive system, ensuring that it can be tailored to any surgeon’s preferred surgical technique."

Each implant is equipped with a large central window for optimum autograft bone placement and includes three locking screws that provide anterior fixation and stability.

All the devices feature an anatomically-shaped lordotic angle to match the convex curvature of the vertebral endplates and are available in sizes ranging from 10mm to 20mm in height.

In 2010, the company entered into a supply assurance agreement with Invibio Biomaterial Solutions, a developer of orthopaedic biomaterials, to provide its Peek-Optima polymer for use in spinal fusion devices.

Binder Biomedical has used Peek-Optima polymer from Invibio in manufacturing the Logic devices.

The radiographic studies also affirmed that the Logic is indicated for stand-alone intervertebral body fusion in patients with degenerative disc disease, at one or two contiguous levels of the lumbosacral spine (L2-S1).

All Logic devices are manufactured in the FDA-registered facilities in the US.

According to GlobalData estimates, the spinal fusion market in the US was valued at $3.9bn in 2012 and is expected to grow at a CAGR of 1.9% to reach $4.5bn by 2019.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network